B. Kumar, “RESVERATROL INHIBITS EXPRESSION OF CANCER-SPECIFIC PENTOSE PHOSPHATE PATHWAY ENZYME TKTL1”, Asian J Pharm Clin Res, vol. 11, no. 6, pp. 332–335, Jun. 2018.